DS

David Standring

IP Idenix Pharmaceuticals: 4 patents #26 of 67Top 40%
UC Università Degli Studi Di Cagliari: 3 patents #8 of 61Top 15%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
Overall (All Time): #826,856 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10525072 2′-branched nucleosides and flaviviridae mutation Jean-Pierre Sommadossi, Paolo La Colla, Vadim Bichko, Lin Qu 2020-01-07
8674085 2′-branched nucleosides and Flaviviridae mutation Jean-Pierre Sommadossi, Paolo LaColla, Vadim Bichko, Lin Qu 2014-03-18
8158606 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies Jean-Pierre Sommadossi, April L. Patty, Maria Seifer 2012-04-17
7928086 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies Jean-Pierre Sommadossi, April L. Patty, Maria Seifer 2011-04-19
7824851 2′-branched nucleosides and Flaviviridae mutation Jean-Pierre Sommadossi, Paolo LaColla, Vadim Bichko, Lin Qu 2010-11-02
7186700 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies Jean-Pierre Sommadossi, April L. Patty, Maria Seifer 2007-03-06